The presence of BCR-ABL in endothelial cells originating from CML patient, raises the question: does the aberration take place even in more primitive cells than LT-HSC (Gunsilius et al., 2000)? The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.